Beiyun Liu, PhD, and Stefan Schattgen, PhD
Beiyun Liu, PhD, is a postdoctoral researcher in the laboratory of Douglas Green, PhD, in the Department of Immunology at St. Jude Children’s Research Hospital. Stefan Schattgen, PhD, is a scientist in the laboratory of Paul Thomas, PhD, in the Department of Immunology at St. Jude Children’s Research Hospital.
Apoptosis or necroptosis? The caspase-8 protein decides
| Oct 20, 2017Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.
Learn moreRigor, reproducibility and resources take center stage
| Jun 27, 2017NIH seminar elucidates new guidelines for grant-funded research as well as allocation of monies to more labs.
Learn moreWhy does the risk of pediatric acute lymphoblastic leukemia relapse vary by race?
| Mar 28, 2017These inherited gene variations may help explain why the risk of relapse for children with acute lymphoblastic leukemia varies by race.
Learn moreCell necroptosis: Can ESCRT-III proteins protect cells from the kill switch?
| Aug 17, 2017Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.
Learn moreBrain studies provide treatment clues in unexpected fields
| Nov 29, 2017Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.
Learn moreMedulloblastoma and microirradiation: Tiny treatments for the most common malignant pediatric brain tumor
| Feb 18, 2019Medulloblastoma may soon be treated by a microirradiator - a machine the size of two refrigerators that beams radiation down to half the width of a credit card.
Learn moreBlazing through new territory to fight a devastating neurodegenerative disease
| Jan 17, 2019Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.
Learn moreGenetic sequencing: How do we put out the fires of genetically driven cancers?
| Nov 8, 2019Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Learn moreOptimizing leukemia treatment through pharmaceutical science
| Jun 19, 2019Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.
Learn moreSeparating fact from fiction using pharmacogenetics
| Oct 8, 2019Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.
Learn more